The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study.
 
Sara Elena Rebuzzi
No Relationships to Disclose
 
Sebastiano Buti
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre
 
Marco Maruzzo
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche
 
Andrea Sbrana
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen
 
Paolo Andrea Zucali
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
 
Emanuela Fantinel
No Relationships to Disclose
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Sara Merler
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Cinzia Baldessari
No Relationships to Disclose
 
Riccardo Ricotta
No Relationships to Disclose
 
Francesco Massari
No Relationships to Disclose
 
Giuseppe Luigi Banna
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen-Cilag; Roche
Patents, Royalties, Other Intellectual Property - "Deep Learning Motion Algorithm for Lung Cancer Early Detection in Embedded Systems" with ST Microelectronics; "Image processing method, corresponding system and computer program product" with ST Microelectronics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Ipsen; Pierre Fabre
 
Mariella Soraru'
No Relationships to Disclose
 
Matteo Santoni
No Relationships to Disclose
 
Alessio Cortellini
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Istituto Gentili; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche; Sanofi; Tesaro
 
Melissa Bersanelli
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer; Roche; Sanofi (Inst); Seqirus
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer/EMD Serono; Pierre Fabre
 
Alessio Signori
No Relationships to Disclose
 
Giuseppe Fornarini
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi